Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature
Amélie Sabine, … , Naoyuki Miura, Tatiana V. Petrova
Amélie Sabine, … , Naoyuki Miura, Tatiana V. Petrova
Published September 21, 2015
Citation Information: J Clin Invest. 2015;125(10):3861-3877. https://doi.org/10.1172/JCI80454.
View: Text | PDF
Research Article Vascular biology

FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature

  • Text
  • PDF
Abstract

Biomechanical forces, such as fluid shear stress, govern multiple aspects of endothelial cell biology. In blood vessels, disturbed flow is associated with vascular diseases, such as atherosclerosis, and promotes endothelial cell proliferation and apoptosis. Here, we identified an important role for disturbed flow in lymphatic vessels, in which it cooperates with the transcription factor FOXC2 to ensure lifelong stability of the lymphatic vasculature. In cultured lymphatic endothelial cells, FOXC2 inactivation conferred abnormal shear stress sensing, promoting junction disassembly and entry into the cell cycle. Loss of FOXC2-dependent quiescence was mediated by the Hippo pathway transcriptional coactivator TAZ and, ultimately, led to cell death. In murine models, inducible deletion of Foxc2 within the lymphatic vasculature led to cell-cell junction defects, regression of valves, and focal vascular lumen collapse, which triggered generalized lymphatic vascular dysfunction and lethality. Together, our work describes a fundamental mechanism by which FOXC2 and oscillatory shear stress maintain lymphatic endothelial cell quiescence through intercellular junction and cytoskeleton stabilization and provides an essential link between biomechanical forces and endothelial cell identity that is necessary for postnatal vessel homeostasis. As FOXC2 is mutated in lymphedema-distichiasis syndrome, our data also underscore the role of impaired mechanotransduction in the pathology of this hereditary human disease.

Authors

Amélie Sabine, Esther Bovay, Cansaran Saygili Demir, Wataru Kimura, Muriel Jaquet, Yan Agalarov, Nadine Zangger, Joshua P. Scallan, Werner Graber, Elgin Gulpinar, Brenda R. Kwak, Taija Mäkinen, Inés Martinez-Corral, Sagrario Ortega, Mauro Delorenzi, Friedemann Kiefer, Michael J. Davis, Valentin Djonov, Naoyuki Miura, Tatiana V. Petrova

×

Figure 13

FOXC2 promotes cell growth arrest and counteracts TAZ signaling.

Options: View larger image (or click on image) Download as PowerPoint
FOXC2 promotes cell growth arrest and counteracts TAZ signaling.
(A) Inc...
(A) Increased proliferation in Foxc2lecKO lymphatic collecting vessels. DNA synthesis was detected by EdU incorporation 2 days after tamoxifen injection. Staining for PROX1 (white) and EdU (red). Dotted green lines outline the collecting vessel. (B) High-magnification images of the area in the yellow box from A (PROX1 staining only). The dashed red lines outline the EdU+ nuclei. Blue arrowheads indicate EdU+/PROX1+ nuclei; blue asterisks indicate EdU+/PROX1– nuclei. (C) Quantification of EdU+/PROX1+ cells in the collecting vessels of control or Foxc2lecKO mice. n = 9; 5 valves scored per mesentery; 2-tailed unpaired Student’s t test; *P < 0.01. (D) Orange transgene expression levels in mesenteric lymphangion (Orangelo) and valve cells (Orangehi) isolated from Prox1-mOrange2+ and Foxc2lecKO Prox1-mOrange2+ pups 2 days after tamoxifen injection. (E) Valve markers Prox1, Itga9, and Cx37 are elevated in Orangehi control LECs. Cx37 is reduced in Foxc2-deficient LECs, as reported previously (10, 26). (F) Enhanced expression of TAZ target genes Ctgf, Cyr61, and Ankrd1 in LECs of Foxc2lecKO mice. Data are representative of 2 independent experiments. The second experiment is shown in Supplemental Figure 10E (see also Supplemental Figure 10 and Supplemental Video 9). Scale bars: 50 μm (A); 100 μm (B).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts